Press | Navamedic

Navamedic ASA: Q3 2020 financial results

“In the third quarter of 2020, we delivered strong growth driven by both the addition of new products such as ThermaCare and positive performance in

MyControl Support – A brand new support program for patients with obesity

Today, Navamedic launches MyControl Support in Sweden – a completely new support program aimed for people with obesity. This is a first of its kind

MyControl – A new website to raise awareness about obesity among healthcare professionals and patients

This is the first step in a wave of communication as part of Navamedic’s effort to increase knowledge about obesity, and to address the fact

Navamedic ASA: Q1 2020 financial results

“We had a solid start to the year delivering revenue growth across all key categories, displaying the attractiveness of the product portfolio and the value

Navamedic ASA: Annual report 2019

Oslo, 30 April 2020 – Navamedic ASA (OSE: NAVA) has published its annual report for 2019. The annual report is attached to this stock exchange

Navamedic ASA: Enters into distribution agreement for ThermaCare® with Angelini Pharma

“We are pleased to announce the agreement with Angelini Pharma for ThermaCare, expanding our portfolio of high-quality products to the benefit of our customers in

Navamedic ASA: Q3 2019 financial results

Oslo, 1 November 2019 – Navamedic ASA (OSE: NAVA) continues to grow and reported revenues of NOK 48.8 million in the third quarter of 2019,

Navamedic ASA: Invitation to third quarter presentation

Navamedic ASA invites you to a presentation of the third quarter 2019 figures. The presentation will take place at Felix Konferansesenter, Aker Brygge, Oslo, Friday